SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Zonagen (zona) - good buy?
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Bruce Rosen who wrote (6362)4/12/1999 1:25:00 AM
From: BDR  Read Replies (2) of 7041
 
<<But to say that since some people on this board speculated that they knew what Schering planned to do in Mexico, your conclusion is that it not happening means there was some kind of failure of Vasomax, strikes me as specious.>>

So it is specious to argue that, because Schering got Vasomax approved for sale in Mexico and some amount of product was placed in the distribution pipeline, they were planning to sell it.

What are you saying Schering's plan was for Vasomax in Mexico? That Schering deliberately intended to not generate any revenues from sales in Mexico after going to all that trouble? What could possibly be the rationale for that? Sales in Mexico would jeopardize FDA approval? Any sales figure would be construed as low by the short conspiracy and therefore zero sales was much better? I am at a loss to understand your interpretation of events in Mexico.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News